lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases
Globally, cardiovascular diseases (CVDs) are among the leading causes of death. In light of the high prevalence and mortality of CVDs, it is imperative to understand the molecules involved in CVD pathogenesis and the signaling pathways that they initiate. This may facilitate the development of more precise and expedient diagnostic techniques, the identification of more effective prognostic molecules and the identification of potential therapeutic targets. Numerous studies have examined the role of lncRNAs, such as TUG1, in CVD pathogenesis in recent years. According to this review article, TUG1 can be considered a biomarker for predicting the prognosis of CVD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Epigenomics - 15(2023), 23 vom: 13. Dez., Seite 1273-1290 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haybar, Habib [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers, Tumor |
|---|
| Anmerkungen: |
Date Completed 05.01.2024 Date Revised 05.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/epi-2023-0242 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365788228 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365788228 | ||
| 003 | DE-627 | ||
| 005 | 20240108142204.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/epi-2023-0242 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1249.xml |
| 035 | |a (DE-627)NLM365788228 | ||
| 035 | |a (NLM)38088089 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haybar, Habib |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2024 | ||
| 500 | |a Date Revised 05.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Globally, cardiovascular diseases (CVDs) are among the leading causes of death. In light of the high prevalence and mortality of CVDs, it is imperative to understand the molecules involved in CVD pathogenesis and the signaling pathways that they initiate. This may facilitate the development of more precise and expedient diagnostic techniques, the identification of more effective prognostic molecules and the identification of potential therapeutic targets. Numerous studies have examined the role of lncRNAs, such as TUG1, in CVD pathogenesis in recent years. According to this review article, TUG1 can be considered a biomarker for predicting the prognosis of CVD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a TUG1 | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a ceRNA | |
| 650 | 4 | |a lncRNA | |
| 650 | 4 | |a prognosis | |
| 650 | 7 | |a RNA, Long Noncoding |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 700 | 1 | |a Sadati, Narjes Sadat |e verfasserin |4 aut | |
| 700 | 1 | |a Purrahman, Daryush |e verfasserin |4 aut | |
| 700 | 1 | |a Mahmoudian-Sani, Mohammad Reza |e verfasserin |4 aut | |
| 700 | 1 | |a Saki, Najmaldin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Epigenomics |d 2009 |g 15(2023), 23 vom: 13. Dez., Seite 1273-1290 |w (DE-627)NLM19811866X |x 1750-192X |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:23 |g day:13 |g month:12 |g pages:1273-1290 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/epi-2023-0242 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 23 |b 13 |c 12 |h 1273-1290 | ||